Case 1:Early Discovery of CB1 Monoclonal Antibodies Based on MegAb

Case 2: UltraVLP and AquaVLP Technology Significantly Improves Immunogenicity

Serum of immunized mice

Case 3: Discovery of SLCX inhibitory antibodies